Bone marrow adipose tissue: Formation, function and regulation

Current Opinion in Pharmacology

Volumn 28, Issue , 2016, Pages 50-56

  Suchacki, Karla J ^a   Cawthorn, William P ^a   Rosen, Clifford J ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; FIBROBLAST GROWTH FACTOR 21; GLUCOCORTICOID; GLYCOGEN; PROTEIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ARTICLE; BONE MARROW; BONE MARROW ADIPOSE TISSUE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CUSHING DISEASE; DISEASE ASSOCIATION; DRUG EFFECT; ESTROGEN THERAPY; GAUCHER DISEASE; HEART FAILURE; HISTOGENESIS; HUMAN; HYPERTENSION; LIPODYSTROPHY; NONHUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; TISSUE EXPANSION; TISSUE STRUCTURE; ANIMAL; CALORIC INTAKE; DRUG EFFECTS; ENERGY METABOLISM; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; BONE MARROW; ENERGY INTAKE; ENERGY METABOLISM; GLYCOGEN; HOMEOSTASIS; HUMANS; PROTEINS; TRIGLYCERIDES;

EID: 84962291383     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2016.03.001     Document Type: Review

References (66)

1. D.D. Feller, and E. Feist Metabolism of adipose tissue. II. Incorporation of propionate carbon into lipides by slices of adipose tissue J Biol Chem 228 1957 275 284
2. G. Fruhbeck Overview of adipose tissue and its role in obesity and metabolic disorders Methods Mol Biol 456 2008 1 22
3. Y.-Y. Chau, R. Bandiera, A. Serrels, O.M. Martínez-Estrada, W. Qing, M. Lee, J. Slight, A. Thornburn, R. Berry, S. McHaffie, and et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source Nat Cell Biol 16 2014 367 375
4. R.V. Shah, V.L. Murthy, S.A. Abbasi, R. Blankstein, R.Y. Kwong, A.B. Goldfine, M. Jerosch-Herold, J.A. Lima, J. Ding, and M.A. Allison Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study JACC Cardiovasc Imaging 7 2014 1221 1235
5. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 21 2000 697 738
6. T.T. Tran, Y. Yamamoto, S. Gesta, and C.R. Kahn Beneficial effects of subcutaneous fat transplantation on metabolism Cell Metab 7 2008 410 420
7. M.E. Lean Brown adipose tissue in humans Proc Nutr Soc 48 1989 243 256
8. T.F. Hany, E. Gharehpapagh, E.M. Kamel, A. Buck, J. Himms-Hagen, and G.K. von Schulthess Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region Eur J Nucl Med Mol Imaging 29 2002 1393 1398
9. W.D. van Marken Lichtenbelt, J.W. Vanhommerig, N.M. Smulders, J.M. Drossaerts, G.J. Kemerink, N.D. Bouvy, P. Schrauwen, and G.J. Teule Cold-activated brown adipose tissue in healthy men N Engl J Med 360 2009 1500 1508
10. A.M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A.B. Goldfine, F.C. Kuo, E.L. Palmer, Y.H. Tseng, A. Doria, and et al. Identification and importance of brown adipose tissue in adult humans N Engl J Med 360 2009 1509 1517
11. K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, M. Taittonen, J. Laine, N.J. Savisto, S. Enerback, and et al. Functional brown adipose tissue in healthy adults N Engl J Med 360 2009 1518 1525
12. S. Kajimura, B.M. Spiegelman, and P. Seale Brown and beige fat: physiological roles beyond heat generation Cell Metab 22 2015 546 559
13. L. Sidossis, and S. Kajimura Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis J Clin Invest 125 2015 478 486
14. I.G. Shabalina, N. Petrovic, J.M. de Jong, A.V. Kalinovich, B. Cannon, and J. Nedergaard UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic Cell Rep 5 2013 1196 1203
15. J.Z. Long, K.J. Svensson, L. Tsai, X. Zeng, H.C. Roh, X. Kong, R.R. Rao, J. Lou, I. Lokurkar, W. Baur, and et al. A smooth muscle-like origin for beige adipocytes Cell Metab 19 2014 810 820
16. M. Harms, and P. Seale Brown and beige fat: development, function and therapeutic potential Nat Med 19 2013 1252 1263
17. F. Villarroya, and A. Vidal-Puig Beyond the sympathetic tone: the new brown fat activators Cell Metab 17 2013 638 643
18. J. Wu, P. Cohen, and B.M. Spiegelman Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev 27 2013 234 250
19. P.K. Fazeli, M.C. Horowitz, O.A. MacDougald, E.L. Scheller, M.S. Rodeheffer, C.J. Rosen, and A. Klibanski Marrow fat and bone - new perspectives J Clin Endocrinol Metab 98 2013 935 945
20. W.P. Cawthorn, E.L. Scheller, B.S. Learman, S.D. Parlee, B.R. Simon, H. Mori, X. Ning, A.J. Bree, B. Schell, D.T. Broome, and et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction Cell Metab 20 2014 368 375
21. M.E. Kricun Red-yellow marrow conversion: its effect on the location of some solitary bone lesions Skeletal Radiol 14 1985 10 19
22. E. Zakaria, and E. Shafrir Yellow bone marrow as adipose tissue Proc Soc Exp Biol Med 124 1967 1265 1268
23. M. Tavassoli Marrow adipose cells. Histochemical identification of labile and stable components Arch Pathol Lab Med 100 1976 16 18
24. M. Tavassoli Ultrastructural development of bone marrow adipose cell Acta Anat (Basel) 94 1976 65 77
25. E.L. Scheller, and C.J. Rosen What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health Ann NY Acad Sci 1311 2014 14 30
26. J. Justesen, K. Stenderup, E.N. Ebbesen, L. Mosekilde, T. Steiniche, and M. Kassem Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis Biogerontology 2 2001 165 171
27. M.J. Devlin, A.M. Cloutier, N.A. Thomas, D.A. Panus, S. Lotinun, I. Pinz, R. Baron, C.J. Rosen, and M.L. Bouxsein Caloric restriction leads to high marrow adiposity and low bone mass in growing mice J Bone Miner Res 25 2010 2078 2088
28. S. Takeshita, T. Fumoto, Y. Naoe, and K. Ikeda Age-related marrow adipogenesis is linked to increased expression of RANKL J Biol Chem 289 2014 16699 16710
29. E.B. Geer, W. Shen, E. Strohmayer, K.D. Post, and P.U. Freda Body composition and cardiovascular risk markers after remission of cushing's disease: a prospective study using whole-body MRI J Clin Endocrinol Metab 97 2012 1702 1711
30. S. Botolin, and L.R. McCabe Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice Endocrinology 148 2007 198 205
31. E.L. Scheller, N. Troiano, J.N. VanHoutan, M.A. Bouxsein, J.A. Fretz, Y. Xi, T. Nelson, G. Katz, R. Berry, C.D. Church, and et al. Use of osmium tetroxide staining with microcomputerized tomography to visualize and quantify bone marrow adipose tissue in vivo Methods Enzymol 537 2014 123 139
32. E.L. Scheller, C.R. Doucette, B.S. Learman, W.P. Cawthorn, S. Khandaker, B. Schell, B. Wu, S.Y. Ding, M.A. Bredella, P.K. Fazeli, and et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues Nat Commun 6 2015 7808
33. J. Chen, Y. Shi, J. Regan, K. Karuppaiah, D.M. Ornitz, and F. Long Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice PLoS ONE 9 2014 e85161
34. Y. Liu, S. Strecker, L. Wang, M.S. Kronenberg, W. Wang, D.W. Rowe, and P. Maye Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma PLoS ONE 8 2013 e71318
35. M.J. Devlin Why does starvation make bones fat? Am J Hum Biol 23 2011 577 585
36. K.R. Georgiou, S.K. Hui, and C.J. Xian Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy Am J Stem Cells 1 2012 205 224
37. M. Dalamaga, K.N. Diakopoulos, and C.S. Mantzoros The role of adiponectin in cancer: a review of current evidence Endocr Rev 33 2012 547 594
38. T.P. Combs, A.H. Berg, M.W. Rajala, S. Klebanov, P. Iyengar, J.C. Jimenez-Chillaron, M.E. Patti, S.L. Klein, R.S. Weinstein, and P.E. Scherer Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin Diabetes 52 2003 268 276
39. A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, X.T. Tigno, B.C. Hansen, A.B. Shanafelt, and G.J. Etgen The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
40. A.A. Ali, R.S. Weinstein, S.A. Stewart, A.M. Parfitt, S.C. Manolagas, and R.L. Jilka Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation Endocrinology 146 2005 1226 1235
41. C.L. Ackert-Bicknell, K.R. Shockley, L.G. Horton, B. Lecka-Czernik, G.A. Churchill, and C.J. Rosen Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I Endocrinology 150 2009 1330 1340
42. L. Tornvig, L. Mosekilde, J. Justesen, E. Falk, and M. Kassem Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice Calcif Tissue Int 69 2001 46 50
43. W.Y. Almawi, D.A. Hess, and M.J. Rieder Multiplicity of glucocorticoid action in inhibiting allograft rejection Cell Transplant 7 1998 511 523
44. H. Fan, and E.F. Morand Targeting the side effects of steroid therapy in autoimmune diseases: the role of GILZ Discov Med 13 2012 123 133
45. B.C. Vande Berg, J. Malghem, F.E. Lecouvet, J.P. Devogelaer, B. Maldague, and F.A. Houssiau Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging Arthritis Rheum 42 1999 1405 1411
46. J. Justesen, L. Mosekilde, M. Holmes, K. Stenderup, J. Gasser, J.J. Mullins, J.R. Seckl, and M. Kassem Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation Endocrinology 145 2004 1916 1925
47. E.A. Lawson, and A. Klibanski Endocrine abnormalities in anorexia nervosa Nat Clin Pract Endocrinol Metab 4 2008 407 414
48. J. Iqbal, L.J. Macdonald, L. Low, J.R. Seckl, C.W. Yau, B.R. Walker, and P.W. Hadoke Contribution of endogenous glucocorticoids and their intravascular metabolism by 11beta-HSDs to postangioplasty neointimal proliferation in mice Endocrinology 153 2012 5896 5905
49. W.P. Cawthorn, E.L. Scheller, S.D. Parlee, H.A. Pham, B.S. Learman, C.M. Redshaw, R.J. Sulston, A.A. Burr, A.K. Das, B.R. Simon, and et al. Expansion of bone marrow adipose tissue during caloric restriction is associated with increased circulating glucocorticoids and not with hypoleptinemia Endocrinology 157 2016 508 521
50. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J Biol Chem 270 1995 12953 12956
51. H. Yki-Jarvinen Thiazolidinediones N Engl J Med 351 2004 1106 1118
52. S. Yaturu, B. Bryant, and S.K. Jain Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men Diabetes Care 30 2007 1574 1576
53. G.R. Beck, N.B. Khazai, G.F. Bouloux, C.E. Camalier, Y. Lin, L.M. Garneys, J. Siqueira, L. Peng, F. Pasquel, D. Umpierrez, and et al. The effects of thiazolidinediones (TZD) on human bone marrow stromal cell differentiation in vitro and in TZD-treated patients with type 2 diabetes Transl Res: J Lab Clin Med 161 2013 145 155
54. C. Canto, and J. Auwerx Cell biology. FGF21 takes a fat bite Science 336 2012 675 676
55. W. Wei, P.A. Dutchak, X. Wang, X. Ding, X. Wang, A.L. Bookout, R. Goetz, M. Mohammadi, R.D. Gerard, P.C. Dechow, and et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma Proc Natl Acad Sci U S A 109 2012 3143 3148
56. P.A. Dutchak, T. Katafuchi, A.L. Bookout, J.H. Choi, R.T. Yu, D.J. Mangelsdorf, and S.A. Kliewer Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones Cell 148 2012 556 567
57. M. Maas, C.E.M. Hollak, E.M. Akkerman, J.M.F.G. Aerts, J. Stoker, and G.J. Den Heeten Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by dixon quantitative chemical shift imaging as a valid parameter Am J Roentgenol 179 2002 961 965
58. G.M. Pastores, and P.A. Meere Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I) Curr Opin Rheumatol 17 2005 70 78
59. J.P. Shillingford The red bone marrow in heart failure J Clin Pathol 3 1950 24 39
60. A. Grey, V. Beckley, A. Doyle, S. Fenwick, A. Horne, G. Gamble, and M. Bolland Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial Eur J Endocrinol 166 2012 1087 1091
61. J. Paccou, P. Hardouin, A. Cotten, G. Penel, and B. Cortet The role of bone marrow fat in skeletal health: usefulness and perspectives for clinicians J Clin Endocrinol Metab 100 2015 3613 3621
62. C.J. Rosen, C. Ackert-Bicknell, J.P. Rodriguez, and A.M. Pino Marrow fat and the bone microenvironment: developmental, functional, and pathological implications Crit Rev Eukaryot Gene Expr 19 2009 109 124
63. F.A. Syed, M.J. Oursler, T.E. Hefferan, J.M. Peterson, B.L. Riggs, and S. Khosla Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women Osteoporosis Int 19 2008 1323 1330
64. A. Bartelt, and J. Heeren Adipose tissue browning and metabolic health Nat Rev Endocrinol 10 2014 24 36
65. V. Peirce, S. Carobbio, and A. Vidal-Puig The different shades of fat Nature 510 2014 76 83
66. P. Trayhurn Hypoxia and adipose tissue function and dysfunction in obesity Physiol Rev 93 2013 1 21